A Multicenter Double-blind Randomized Sham-controlled Trial Assessing the EndoBarrier Duodenal-jejunal Bypass Liner for the Treatment of Poorly Controlled type 2 Diabetes Mellitus with Concomitant Obesity
DJBL met primary glycemic control efficacy and primary safety endpoints, while providing clinically significant weight loss, and comorbidity improvement.
Authors
- Timothy R. Koch (ORCID: https://orcid.org/0000-0002-8026-9653)
- Nicholas J. Shaheen (ORCID: https://orcid.org/0000-0001-6602-5647)
- Thomas R. McCarty (ORCID: https://orcid.org/0000-0003-4517-5261)
- Barham K. Abu Dayyeh (ORCID: https://orcid.org/0000-0001-8084-7225)
- Winfield Scott Butsch (ORCID: https://orcid.org/0000-0001-7137-9423)
- Christopher C. Thompson (ORCID: https://orcid.org/0000-0002-6105-5270)
- Keith S. Gersin
- Kevin M. Reavis
- Shelby Sullivan (ORCID: https://orcid.org/0000-0001-8550-0220)
- Allison R. Schulman (ORCID: https://orcid.org/0000-0002-3913-8045)
- Pichamol Jirapinyo (ORCID: https://orcid.org/0000-0001-5273-6851)
- Philip R. Schauer (ORCID: https://orcid.org/0000-0002-4029-7537)
- Erik B. Wilson
- Caroline M. Apovian
- Stacy A. Brethauer
Institutions
- Pennington Biomedical Research Center (US)
- Brigham and Women's Hospital (US)
- Cleveland Clinic (US)
- Mayo Clinic (US)
- University of Michigan (US)
- Carilion Roanoke Memorial Hospital (US)
- Salem VA Medical Center (US)
- Carolinas Medical Center (US)
- WinnMed (US)
- Oregon Clinic (US)
- Methodist Hospital (US)
- University of North Carolina System (US)
- The Ohio State University (US)
- The University of Texas Health Science Center at Houston (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1097/sla.0000000000006974
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00